Hodis HN - Search Results

1

Menopausal hormone therapy for primary prevention: why the USPSTF is wrong.

Langer RD, Simon JA, Pines A, Lobo RA, Hodis HN, Pickar JH, Archer DF, Sarrel PM, Utian WH. Langer RD, et al. Among authors: hodis hn. Climacteric. 2017 Oct;20(5):402-413. doi: 10.1080/13697137.2017.1362156. Epub 2017 Aug 14. Climacteric. 2017. PMID: 28805475

2

Cardioprotective effects of individual conjugated equine estrogens through their possible modulation of insulin resistance and oxidation of low-density lipoprotein.

Wilcox JG, Hwang J, Hodis HN, Sevanian A, Stanczyk FZ, Lobo RA. Wilcox JG, et al. Among authors: hodis hn. Fertil Steril. 1997 Jan;67(1):57-62. doi: 10.1016/s0015-0282(97)81856-0. Fertil Steril. 1997. PMID: 8986684 Free article. Clinical Trial.

3

Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP; Estrogen in the Prevention of Atherosclerosis Trial Research Group. Hodis HN, et al. Ann Intern Med. 2001 Dec 4;135(11):939-53. doi: 10.7326/0003-4819-135-11-200112040-00005. Ann Intern Med. 2001. PMID: 11730394 Clinical Trial.

4

Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.

Hodis HN, Mack WJ, Lobo R. Hodis HN, et al. Curr Atheroscler Rep. 2002 Jan;4(1):52-8. doi: 10.1007/s11883-002-0062-y. Curr Atheroscler Rep. 2002. PMID: 11772423 Review.

5

Antiatherosclerosis interventions in women.

Hodis HN, Mack WJ, Lobo R. Hodis HN, et al. Am J Cardiol. 2002 Jul 3;90(1A):17F-21F. doi: 10.1016/s0002-9149(02)02420-7. Am J Cardiol. 2002. PMID: 12106635 Review.

6

What is the cardioprotective role of hormone replacement therapy?

Hodis HN, Mack WJ, Lobo R. Hodis HN, et al. Curr Atheroscler Rep. 2003 Jan;5(1):56-66. doi: 10.1007/s11883-003-0069-z. Curr Atheroscler Rep. 2003. PMID: 12562544 Review.

7

Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.

Mack WJ, Hameed AB, Xiang M, Roy S, Slater CC, Stanczyk FZ, Lobo RA, Liu CR, Liu CH, Hodis HN. Mack WJ, et al. Among authors: hodis hn. Atherosclerosis. 2003 May;168(1):91-8. doi: 10.1016/s0021-9150(03)00052-2. Atherosclerosis. 2003. PMID: 12732391 Clinical Trial.

8

Randomized controlled trial evidence that estrogen replacement therapy reduces the progression of subclinical atherosclerosis in healthy postmenopausal women without preexisting cardiovascular disease.

Hodis HN, Mack WJ, Lobo RA. Hodis HN, et al. Circulation. 2003 Jul 8;108(1):e5; author reply e5. doi: 10.1161/01.CIR.0000080080.76333.38. Circulation. 2003. PMID: 12847059 No abstract available.

9

Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH; Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group. Hodis HN, et al. N Engl J Med. 2003 Aug 7;349(6):535-45. doi: 10.1056/NEJMoa030830. N Engl J Med. 2003. PMID: 12904518 Free article. Clinical Trial.

10

Elevated subclinical atherosclerosis associated with oophorectomy is related to time since menopause rather than type of menopause.

Mack WJ, Slater CC, Xiang M, Shoupe D, Lobo RA, Hodis HN. Mack WJ, et al. Among authors: hodis hn. Fertil Steril. 2004 Aug;82(2):391-7. doi: 10.1016/j.fertnstert.2004.01.034. Fertil Steril. 2004. PMID: 15302289 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page